TNDM TANDEM DIABETES CARE INC

8-K Current Report

Filed: February 27, 2026

Health Care

Surgical & Medical Instruments & Apparatus

TANDEM DIABETES CARE INC (TNDM) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

• Convertible notes issued Feb 24, 2026 via Rule 144A private placement to qualified institutional buyers
• Maximum 11,152,410 shares of Common Stock issuable upon conversion at initial max rate of 37.1747 shares per $1,000 principal

+3 more insights

Item 8.01 · Other Events

• TNDM launched a convertible notes offering ("the Notes"), announced Feb 23 and priced Feb 25, 2026
• Proceeds use not fully disclosed here — stated as "expected uses" subject to change, signaling dilution or debt risk for equity holders

+1 more insights

Get deeper insights on TANDEM DIABETES CARE INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.